Deferasirox, an iron-chelating agent, alleviates acute lung inflammation by inhibiting neutrophil activation and extracellular trap formation
Authors:
Open Access
- 16 September 2020
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (9)
Abstract
Reactive oxygen species (ROS) production by neutrophils induces pulmonary endothelial cell damage and results in acute lung injury (ALI). We previously reported that deferasirox (DFS), an iron-chelating agent, inhibits the ROS production and neutrophil extracellular trap (NET) formation induced by phorbol myristate acetate and formylmethionylleucylphenylalanine in vitro. In the present study, we investigated the effects of DFS in vivo using a mouse model of lipopolysaccharide (LPS)-induced ALI. After DFS administration for 7 days, ALI was induced in mice by LPS via intratracheal administration. LPS treatment induced neutrophil invasion in the lung tissues, along with NET formation and a significant increase in the quantity of double-stranded DNA in the bronchoalveolar lavage fluid, while pre-administered DFS inhibited these phenomena. However, alteration of neutrophil morphology in the cytoplasm in terms of shape and vacuolization was not inhibited by the pre-administration of DFS, possibly through ROS production. DFS suppressed neutrophil invasion into lung tissues and reduced the double-stranded DNA content released by the neutrophils. These results suggest that DFS can potentially be used to prevent diseases related to neutrophil activation including ALI, thrombosis, and vascular endothelial dysfunction.Keywords
Funding Information
- Sysmex Corporation
This publication has 25 references indexed in Scilit:
- Deferasirox Reduces Oxidative Stress in Patients With Transfusion DependencyJournal of Clinical Medicine Research, 2013
- Platelets induce neutrophil extracellular traps in transfusion-related acute lung injuryJournal of Clinical Investigation, 2012
- Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of HistonesPLOS ONE, 2012
- Transfusion-related acute lung injury: from bedside to bench and backBlood, 2011
- Deferasirox is a powerful NF- B inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavengingHaematologica, 2010
- Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromesHaematologica, 2010
- Regulation of the autophagic machinery in human neutrophilsEuropean Journal of Immunology, 2010
- The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1Cancer Science, 2009
- Novel cell death program leads to neutrophil extracellular trapsJournal of Cell Biology, 2007
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004